Cloud Genomics Market Report 2026

The cloud genomics market size has grown exponentially in recent years. It will grow from $3.91 billion in 2025 to $4.81 billion in 2026 at a compound annual growth rate (CAGR) of 23.2%. The growth in the historic period can be attributed to advancements in DNA sequencing technologies, increasing volume of genomic data generation, expansion of academic and clinical genomics research, rising use of bioinformatics tools, demand for high-performance computing resources.

The cloud genomics market size is expected to see exponential growth in the next few years. It will grow to $10.97 billion in 2030 at a compound annual growth rate (CAGR) of 22.9%. The growth in the forecast period can be attributed to increasing adoption of precision medicine initiatives, rising investments in genomics research infrastructure, growing integration of ai in genetic analysis, expansion of population-scale genomic studies, increasing need for interoperable cloud platforms. Major trends in the forecast period include increasing adoption of cloud-based genomic data platforms, rising use of AI-driven genomic analytics, growing demand for scalable data storage solutions, expansion of collaborative genomic research environments, enhanced focus on data security and compliance.

Rising investments in genomics research are expected to drive the growth of the cloud genomics market. Genomics research involves analyzing an organism’s entire DNA sequence to study gene functions, interactions, and their effects on biological processes. Investment in this area is increasing due to its potential to enable personalized medicine, providing more accurate diagnoses and targeted treatments based on individual genetic profiles. As genomics research generates vast amounts of data, it fuels demand for cloud genomics solutions that offer scalable, efficient, and cost-effective infrastructure for storage and analysis. For example, in March 2024, the US-based National Human Genome Research Institute (NHGRI) reported a budget request of US$663.7 million for fiscal year 2025, supporting human genomics research, technology development, and clinical genomics integration. This ongoing investment is thus driving market growth for cloud genomics.

Key players in the cloud genomics market are focusing on advanced software solutions to accelerate genomic data analysis. Software accelerators optimize data processing and computational tasks, improving the speed and efficiency of complex applications. For instance, in January 2023, US-based QIAGEN Digital Insights (QDI) launched the QIAGEN CLC Genomics Workbench Premium, which addresses bottlenecks in next-generation sequencing (NGS) data analysis. It incorporates LightSpeed technology, rapidly converting raw FASTQ sequencing data into interpretable VCF-format genetic variant lists. The platform can analyze a whole human genome at 34x coverage in just 25 minutes and a 50x whole exome in 90 seconds using typical cloud environments. This enables cost-effective whole genome and exome sequencing, with the option to run efficiently on existing local hardware while maintaining high-speed performance.

In May 2025, Netherlands-based QIAGEN acquired US-based Genoox for $80 million. This acquisition strengthens QIAGEN’s AI-powered genomic interpretation capabilities and expands its Digital Insights portfolio, enabling scalable, cloud-based decision-support tools for clinical laboratories. Genoox specializes in cloud genomics, enhancing QIAGEN’s offerings in the market.

Major companies operating in the cloud genomics market are Microsoft Corp., Amazon Web Services Inc., F. Hoffmann-La Roche Ltd., IBM Corporation, Oracle Corporation, Thermo Fisher Scientific Inc., Illumina Inc., PerkinElmer Inc., QIAGEN N.V., Element Biosciences Inc., Human Longevity Inc., Seven Bridges Genomics, DNAnexus Inc., Lifebit Biotech Ltd., Fabric Genomics Inc., PierianDx Inc., Veritas Genetics Inc., WuXi, NantOmics LLC, Saphetor SA, Nebula Genomics, Gene by Gene Ltd.

North America was the largest region in the cloud genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cloud genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the cloud genomics market by increasing costs of imported servers, high-performance computing systems, storage hardware, and networking equipment essential for genomic data processing. Research institutions and biotechnology companies in North America and Europe are most affected due to reliance on specialized imported infrastructure, while Asia-Pacific faces higher costs in cloud hardware deployment. These tariffs are increasing operational expenditures and slowing infrastructure upgrades. However, they are also driving investments in domestic cloud infrastructure, regional data centers, and optimized software-driven genomics solutions.

The cloud genomics market research report is one of a series of new reports that provides cloud genomics market statistics, including cloud genomics industry global market size, regional shares, competitors with a cloud genomics market share, detailed cloud genomics market segments, market trends and opportunities, and any further data you may need to thrive in the cloud genomics industry. This cloud genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cloud genomics refers to the use of cloud computing technology to manage and analyze large volumes of genomic data. It provides flexible storage and high-performance computing resources, enabling researchers to efficiently process the vast amounts of genetic information generated by sequencing technologies.

The key components of cloud genomics include software, hardware, and services. Software encompasses cloud-based platforms, applications, and analytical tools for storing, processing, and analyzing genomic data. These solutions can be deployed via public, private, or hybrid cloud models and are applied in areas such as clinical diagnostics, drug discovery and development, personalized medicine, and research. End-users include hospitals and clinics, research and academic institutions, and pharmaceutical and biotechnology companies, among others.

The cloud genomics market consists of revenues earned by entities by providing services such as genome data storage, sequence data analysis, collaborative data sharing, and data security services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloud genomics market also includes sales of high-throughput DNA sequencers, storage arrays, GPU-based accelerators, and data transfer appliances. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.